Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
Status:
Terminated
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This is a treatment guideline for HLA-Haploidentical hematopoietic stem cell transplant
(HSCT) using a reduced intensity conditioning (RIC) regimen. This regimen, consisting of
fludarabine, cyclophosphamide and low dose total body irradiation (TBI), is designed for the
treatment of patients with advanced and/or high risk diseases.